Get Tris Lean Cough Syrup online
$1,200.00 – $4,500.00
Promethazine HCl and Codeine Phosphate Oral Solution is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold in patients 18 years of age and older.
Tris, Promethazine HCl and Codeine Phosphate Oral Solution for use in adult patients for whom the benefits of cough suppression are expected to outweigh the risks, and in whom an adequate assessment of the etiology of the cough has been made.
Tris Lean Cough Syrup Online
Tris Lean Cough Syrup Online, Tris Pharma has announced the introduction of its promethazine and codeine syrup (promethazine HCl and codeine phosphate oral solution.
Firstly, The product is manufactured at the company’s facility in Monmouth Junction, N.J.
Secondly, Tris’ promethazine and codeine syrup will be available in 16-oz. bottles in dosage strengths of 6.25 mg and 10 mg per 5-ml oral solution.
Furthermore, The drug is indicated for temporary relief of coughs and uppers respiratory system associated with allergies or the common cold in patients 18 years of age and older.
The drug’s market size was for the 12 months ended December 2017 was roughly $8 million, according to IQVIA data.
Promethazine Hydrochloride And Codeine Phosphate with NDC 27808-065 is a human prescription drug product labeled by Tris Pharma Inc.
The generic name of Promethazine Hydrochloride And Codeine Phosphate is promethazine hydrochloride and codeine phosphate.
The product’s dosage form is a solution and is administered via the oral form.
Promethazine HCl and Codeine Phosphate Oral Solution is not recommended for use in pregnant women,
Prolong use of Promethazine HCl and Codeine Phosphate Oral Solution during pregnancy can result in neonatal opioid withdrawal syndrome,
Finally, which may be life-threatening if not recognized and treated, and requires management according to protocols developed by neonatology experts.
If Promethazine HCl and Codeine
Phosphate Oral Solution is used for a prolonged period in a pregnant woman,
advise the patient of the risk of neonatal opioid withdrawal syndrome and ensure that appropriate treatment will be available.
1, 2, 3, 4, 5, 6, 7, 8, 9, 10